Piperidin-4-ol → HCID 58494270, compound
Reaction equation
CS[C:3]1[N:4]=[C:5]([NH:14][C:15]2[CH:20]=[CH:19][CH:18]=[C:17]([C:21]([F:24])([F:23])[F:22])[CH:16]=2)[C:6]2[C:12](=[O:13])[NH:11][CH:10]=[CH:9][C:7]=2[N:8]=1.[OH:25][CH:26]1[CH2:31][CH2:30][NH:29][CH2:28][CH2:27]1>>[OH:25][CH:26]1[CH2:31][CH2:30][N:29]([C:3]2[N:4]=[C:5]([NH:14][C:15]3[CH:20]=[CH:19][CH:18]=[C:17]([C:21]([F:24])([F:23])[F:22])[CH:16]=3)[C:6]3[C:12](=[O:13])[NH:11][CH:10]=[CH:9][C:7]=3[N:8]=2)[CH2:28][CH2:27]1Participants
3
Procedure
The title compound was prepared as described in Example 1g by starting from 2-(methylthio)-4-(3-(trifluoromethyl)phenylamino)pyrido[4,3-d]pyrimidin-5(6H)-one (100 mg, 0.26 mmol) and 4-hydroxypiperidine to yield the title compound (73 mg) as white solids. MS m/z: 406 (M+H)+, 1H NMR (300 MHz), δ ppm 1.21-1.35 (m, 4H), 3.76-3.78 (m, 1H), 4.26-4.28 (m, 4H), 6.17 (d, J=7.2 Hz, 1H), 7.38-7.68 (m, 4H), 7.90 (s, 1H), 8.61 (s, 1H), 11.42 (s, 1H), 12.10 (s, 1H).
Workup
- customThe title compound was prepared
Sources & evidence
- ORD record
- ord-14387494dae049b9bc2a29cb08273c08
- Source dataset
- uspto-grants-2013_03
- Patent number
- US08404677B2
Reaction notes
Loading…